Glooko, Inc.
https://www.glooko.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Glooko, Inc.
Gut-Brain Connect: metaMe’s Digital Therapeutic Hopes To Rewire IBS Treatment
metaMe Health CEO and ex-Takeda executive Tim Rudolphi and partner firm Indegene’s senior vice president Marut Setia explained their plans for the FDA-authorized, gut-directed hypnotherapy Regulora, including an openness to outcomes-based pricing and the wider go-to-market strategy.
Gut-Brain Connect: How metaMe’s Digital Therapeutic Hopes To Rewire IBS Treatment
metaMe Health CEO and ex-Takeda executive Tim Rudolphi and partner firm Indegene’s senior vice president Marut Setia discuss with Scrip plans for the FDA-authorized, gut-directed hypnotherapy Regulora, including an openness to outcomes-based pricing and the wider go-to-market strategy.
Exec Chat: Glooko CEO Talks Differentiation, Collaboration And The Future Of Digital Diabetes Solutions
Medtech Insight talked to Russ Johannesson about Glooko’s connected diabetes care strategy, including its recent agreement with John Hopkins HealthCare Solutions and acquisition of Diabnext, a French competitor.
Minute Insight: Glooko Acquires Berlin-Based AI Company Xbird To Expand Analytics Capabilities
Glooko said it will integrate Xbird’s JITAI digital coaching platform into its existing diabetes management platform.
Company Information
- Industry
- Biotechnology
-
Medical Devices
- Monitoring Equipment & Devices
-
Digital Health
- Disease Management
- Artificial Intelligence
- Other Names / Subsidiaries
-
- Diasend AB